论文部分内容阅读
中国医药工业长期仿制的模式将受到知识产权保护和“复关”的双重挑战。 河北省医药工业五六十年代在全国曾占垄断地位,如今已名落孙山。 认清形势、奋起直追已势在必行。
The model of long-term imitation of the Chinese pharmaceutical industry will be subject to the double challenges of intellectual property protection and “revalence”. In the 1950s and 1960s, the pharmaceutical industry in Hebei Province once occupied a monopoly position in the country and it is now known as the Sun Shan. It is imperative to understand the situation and catch up.